Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
NFT Ltd prices US$2 million public offering at US$4.60 per unit

NFT Ltd prices US$2 million public offering at US$4.60 per unit

ReutersReuters2026/08/28 20:06
  • NFT Ltd. priced a public offering expected to raise about US$ 2 million in gross proceeds.
  • Units priced at US$ 4.6 include one Class A ordinary share or a pre-funded warrant, plus one common warrant.
  • Pre-funded units priced at US$ 4.56 reflect a US$ 0.04 pre-funded warrant exercise price.
  • Common warrants are immediately exercisable at US$ 4.6, subject to anti-dilution adjustments, expiring on the fifth anniversary.
  • Closing is expected on Aug. 24, 2026; proceeds earmarked for working capital, general corporate purposes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NFT Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-095036), on August 28, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.

Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.

智通财经2026/08/29 03:22
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.